EMA receives application for conditional authorisation of first COVID-19 treatment in the EU 09 Jun 2020 Press Packagin… EMA has now received an application for conditional marketing authorisation (CMA) of the antiviral medicine remdesivir for the treatment of COVID-19 and has formally started its evaluation. Read more about EMA receives application for conditional authorisation of first COVID-19 treatment in the EU Log in or register to post comments Tags conditional marketing authorisation rolling review human medicines committee
